OnePin Peptide Library · Cognitive & Mood
Cerebrolysin
FPF 1070 · FPE 1070 · Cere
Cerebrolysin is a porcine brain-derived peptide preparation consisting of low-molecular-weight neuropeptides and free amino acids obtained by standardized enzymatic breakdown of purified pig brain proteins. Manufactured by EVER Neuro Pharma (Austria), it has been used clinically for over 40 years, primarily in Europe, Asia, and Latin America, for the treatment of neurological conditions including stroke, traumatic brain injury, and dementia.,The preparation contains biologically active peptides that mimic the action of endogenous neurotrophic factors, including brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). This neurotrophic activity is believed to support neuronal survival, promote synaptic plasticity, and facilitate neuroregeneration following brain injury.,Cerebrolysin is approved for clinical use in over 45 countries but is not FDA-approved in the United States. Multiple randomized controlled trials have been conducted, particularly in stroke and Alzheimer's disease, with mixed results. A Cochrane review noted methodological concerns in many published trials. Despite this, it remains widely prescribed in many countries as a neuroprotective and neuroregenerative agent.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
How it works
Contains peptide fragments that mimic neurotrophic factors (BDNF, NGF, CNTF, GDNF-like activity), activating neuronal survival pathways including PI3K/Akt and MAPK/ERK signaling cascades.,Promotes neuroplasticity by enhancing dendritic sprouting, synaptogenesis, and long-term potentiation (LTP) in hippocampal and cortical neurons.,Exerts neuroprotective effects by reducing excitotoxicity, oxidative stress, and neuroinflammation. May inhibit calpain-mediated neuronal damage and reduce apoptotic cell death after ischemic insult.
Contains peptide fragments that mimic neurotrophic factors (BDNF, NGF, CNTF, GDNF-like activity), activating neuronal survival pathways including PI3K/Akt and MAPK/ERK signaling cascades.,Promotes neuroplasticity by enhancing dendritic sprouting, synaptogenesis, and long-term potentiation (LTP) in hippocampal and cortical neurons.,Exerts neuroprotective effects by reducing excitotoxicity, oxidative stress, and neuroinflammation. May inhibit calpain-mediated neuronal damage and reduce apoptotic cell death after ischemic insult.
What to expect
Days 1-7: Generally well tolerated with minimal immediate effects. Some patients report improved alertness or mental energy within the first week.
Evidence
Interactions & stacking
What's safe to combine, and what belongs in a separate pin.
Safe & synergistic
Keep separate
Pharmacokinetics
Storage. Store refrigerated at 2-8C. Protect from light. Do not freeze.
Regulatory status
Approved for clinical use in over 45 countries (including Austria, Germany, Russia, China, South Korea, and many Latin American nations). Not FDA-approved in the United States. Classified as a prescription pharmaceutical in approved markets.
Put it to work
Calculate, log & track
Open Cerebrolysin straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open Cerebrolysin in the app →Go deeper
The guide & community
The complete Cerebrolysin walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗